MegaBlog- – this is an amalgamation of posts from popular trading blogs . This section will allow you to track interesting topics and track popular trends in trading., understand what traders live.
Biotechnology company Eliem Therapeutics, developing drugs for the treatment of disorders of nervous excitability in phase 2a research, attracted 80 million dollars, releasing 6,4 million shares in 12,50 Dollars, as planned. The company offered at 0,4 million shares more, what was stated.
Southern States Bancshares, Bank of Alabama with 15 branches in Alabama and Georgia, attracted 38 million dollars, releasing 2 million shares (50% secondary) on 19 dollars - the minimum price of the stated range from 19 to 21 dollar. Taking into account the actual price of the IPO, the market value of the company will be 166 million dollars.
Biotechnology company Dermata Therapeutics, developing drugs for the treatment of skin diseases based on badyagi in 3 research phase, attracted 18 million dollars, releasing 2,6 million packages of 7 dollars - the minimum price of the stated range from 7 to 9 Dollars.
9 August biotech company Eliem Therapeutics, developing drugs for the treatment of disorders of nervous excitability in phase 2a research, announced a reduction in the size of the upcoming IPO.
10 August investment fund ROX Financial LP, including the only logistics center in Oakley, California, withdrew its IPO application. Previously, the company applied for attraction 83 million dollars, releasing 8,3 million shares in 10 Dollars.
Biotechnology company IN8bio, develops allogeneic drugs for cancer treatment based on gamma-delta T cells, located in 1 research phase, attracted 40 million dollars, releasing 4 million shares in 10 dollars - the minimum price of the stated range from 10 to 12 Dollars.
Biotechnology company Omega Therapeutics, developing gene therapy for cancer and other diseases in the preclinical stage of research, attracted 126 million dollars, releasing 7,4 million shares in 17 dollars - within the stated range from 16 to 18 Dollars.
Biotechnology company Tenaya Therapeutics, developing several drugs for the treatment of cardiovascular diseases in the preclinical stage of research, attracted 180 million dollars, releasing 12 million shares in 15 dollars - within the stated range from 14 to 16 Dollars.
RxSight Company, commercial supplier of premium customizable intraocular lenses, which can be installed after cataract surgery, attracted 118 million dollars, releasing 7,4 million shares in 16 dollars - the minimum price of the stated range from 16 to 18 Dollars.
Preclinical Biotechnology Company Immuneering, specializing in influencing signaling pathways for the treatment of cancer and neurological diseases, attracted 113 million dollars, releasing 7,5 million shares in 15 dollars - within the stated range from 14 to 16 Dollars.